Name: Metabolism and Metabolomics of Liver in Health and Disease (en Inglés)
SKU: 54769837
Price: 237.77 PEN
Availability: InStock
Author: Wahli, Walter ; Guillou, Hervé
ISBN: 9783039436354

portada Metabolism and Metabolomics of Liver in Health and Disease (en Inglés)

Metabolism and Metabolomics of Liver in Health and Disease (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Wahli, Walter ; Guillou, Hervé

Idioma

Inglés

N° páginas

268

Encuadernación

Tapa Dura

Dimensiones

24.4x17x2.2 cm

Peso

0.78 kg.

ISBN13

9783039436354

Categorías

Biología, ciencias de la vida

Metabolism and Metabolomics of Liver in Health and Disease (en Inglés)

Wahli, Walter ; Guillou, Hervé (Autor) · Mdpi AG · Tapa Dura

Más barato Libro Nuevo Importado

Envío: 17 a 22 días háb.

S/ 528,37S/ 237,77

-55%

Más rápido Libro Nuevo Importado

Envío: 14 a 19 días háb.

S/ 528,90S/ 238,00

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo Más barato

Quedan 100 unidades

S/ 237,77

Llega entre el 27 Oct y el 04 Nov a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Metabolism and Metabolomics of Liver in Health and Disease (en Inglés)"

Women and men have probably never been concerned as much by their health as during this COVID-19 pandemic. In this context, lifestyle habits continue to be promoted as allies for daily prevention against diseases. This is valid also for metabolic diseases, among which many affect the liver and are risk factors for aggravating the disease course of COVID-19. In fact, liver diseases are currently a major global health problem. There is a huge range of liver diseases and non-alcoholic fatty liver disease (NAFLD) is the most common chronic hepatic condition, which in some patients progresses to cirrhosis and liver cancer. Currently, substantial efforts are being made to better understand NAFLD, especially, because there is no U.S. Food and Drug Administration (FDA)-approved pharmacological therapy. To explore this disease, metabolomics is the most recently developed omics technology after genomics, transcriptomics, and proteomics. Metabolomics is the large-scale analysis of molecules, known as metabolites that are intermediate or end products of metabolism found within cells, tissues, and biofluids. This technology has a very high potential to identify biomarker candidates for the future development of new therapeutics. The book features articles that address metabolomics technology and its use to document different liver functions and dysfunctions, with a major focus on NAFLD.